HeidiDKlepinMD, MS, FASCO

Professor, Internal Medicine, Wake Forest University School of Medicine

Dr. Klepin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
Wake Forest University Baptist Medical CenterFellowship, Geriatric Medicine (Internal Medicine), 2001 - 2002
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1998 - 2001
Medical University of South CarolinaClass of 1998

CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012

PubMed

8 citations
Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial.
Mina S Sedrak, Can-Lan Sun, Jingran Ji, Harvey J Cohen, Cary P Gross
Journal of Clinical Oncology. 2023-01-10
25 citations
Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: a Young SIOG review paper
Nina Rosa Neuendorff, Kah Poh Loh, Alice S. Mims, Konstantinos Christofyllakis, Wee Kheng Soo
Blood Advances. 2020-02-25
53 citations
Cancer and Its Association With the Development of Coronary Artery Calcification: An Assessment From the Multi‐Ethnic Study of Atherosclerosis
Matthew C. Whitlock, Joseph Yeboah, Gregory L. Burke, Haiying Chen, Heidi D. Klepin
Journal of the American Heart Association. 2015-11-09

Journal Articles

Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer
Aminah Jatoi, Antonio C Wolff, Harvey Jay Cohen, Rachel A Freedman, Gustav Magrinat, Julie Gralow, Gretchen Kimmick, Heidi D Klepin, Harold Burstein, Hyman Muss, Jeann..., Journal of the American Geriatrics Society

Abstracts/Posters

Alliance A041701 - a Randomized Phase 2/3 Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia (AML) Receiving Int...
Heidi D. Klepin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Aging and Hematologic Disorders: Exploring the Evidence
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Friday Scientific Workshop on Hematology and Aging: From Bleeding Disorders to Malignant Hematology
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Hypertension and use of bevacizumab among patients treated in community settings.
2019 ASCO Annual Meeting - 6/1/2019
Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Hematology & Aging: Scientific Advances From Sickle Cell Disease to Malignant Hematology
60th American Society of Hematology Annual Meeting - 11/30/2018
Strategies to Improve the Evidence Base: A Call to Action
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Join now to see all

Other

Pretreatment evaluation and prognosis of acute myeloid leukemia in older adults
Klepin HD, Larson RA
http://www.uptodate.com/contents/pretreatment-evaluation-and-prognosis-of-acute-myeloid-leukemia-in-
UpToDate, Wolters Kluwer Health - 2012-11-13

First-Line Cyramza in NSCLC Gets Split Decision from FDA PanelFebruary 27th, 2020
FDA Panel Split on PARP Inhibitor for Pancreatic CancerDecember 17th, 2019
ODAC Cautiously Backs Keytruda in Early Bladder CancerDecember 17th, 2019
Join now to see all